Tirzepatide 10mg
Dual GIP / GLP-1 receptor agonist
≥99.0%
Third-Party
COA
Also available in 15mg · 30mg · 45mg · 60mg — compare all sizes
Complete your research kit
Also searched as: Tirz, GIP/GLP-1 dual agonist
Third-Party Tested
HPLC & mass spec verified purity
Batch Specific COA
Certificate with every batch
Discreet Packaging
Plain, unbranded, tamper-evident
Same-Day Dispatch
Before 2PM AEST, Australia-wide
Tirzepatide 10mg is a research compound supplied for laboratory and scientific investigation. Tirzepatide is a synthetic peptide designed to interact with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor pathways. Tirzepatide 10mg Australia is of particular research interest for studying incretin signalling, metabolic pathways and receptor activity under controlled experimental conditions.
What Is Tirzepatide 10mg?
Tirzepatide is a single peptide compound characterised by dual agonist activity at GIP and GLP-1 receptors. These receptors participate in complex endocrine and metabolic signalling networks.
The 10mg format provides researchers with a defined nominal quantity for laboratory studies. Research involving tirzepatide has examined receptor pharmacology, glucose-dependent signalling, energy metabolism and interactions between the two incretin pathways.
Key Research Areas
Tirzepatide has attracted scientific interest across several areas, including:
Findings from experimental or clinical research should not be interpreted as establishing the suitability of an RUO product for human use.
Why Researchers Study Tirzepatide
An important feature of tirzepatide is its ability to activate two distinct incretin receptors within a single molecular structure. This makes it useful for investigating how GIP and GLP-1 pathways interact and how combined receptor activity differs from isolated receptor signalling.
Researchers may also use controlled models to examine downstream cellular responses associated with these receptor systems.
Key Research Areas at a Glance
Tirzepatide 10mg in Australia
Researchers looking for Tirzepatide 10mg Australia should confirm current stock, price, domestic shipping arrangements and batch-specific analytical documentation before ordering. Product information should be checked against the current CoA where available.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
Quality assessment is particularly important when selecting Tirzepatide 10mg for research. Researchers should review the relevant batch documentation for information about nominal vial content, analytical purity and testing methods.
Where available, a batch-specific Certificate of Analysis (CoA) can provide analytical information associated with the supplied material. Analytical purity should not be interpreted as evidence of clinical safety or therapeutic effectiveness.
Storage & Handling
Storage and Laboratory Handling
- Lyophilised storage: Follow the verified storage conditions supplied with the product or batch documentation.
- After reconstitution: Where validated stability information is not supplied, researchers should follow their established laboratory protocol and applicable batch documentation.
Reconstitution calculator: Tirzepatide 10mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
Tirzepatide 10mg: Frequently Asked Questions
It is a 10mg research format of the dual GIP/GLP-1 receptor agonist tirzepatide.
It activates GIP and GLP-1 receptors, allowing investigation of associated signalling pathways.
They allow researchers to examine combined incretin-receptor signalling.
Research includes incretin signalling, metabolic regulation and energy-balance mechanisms.
Refer to the product's current analytical documentation for verified purity information.
Check the relevant batch documentation or CoA library for current availability.
Follow verified batch-specific storage and laboratory handling instructions.
Check the supplier's current listing for Australian availability, price, stock and domestic shipping details.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.
Purchase Other Quantities
Tirzepatide is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.
Reviews
There are no reviews yet.